Drug & intervention

rilpivirine

RxCUI 1102270

Clinical trials19
Recruiting1
Related conditions16
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Clinical trials

19 shown
Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral TherapyNCT07682961 · 2026-07-14
RECRUITING
A Study of Switching to RPV Plus Other ARVs in HIV-1-infected Children (Aged 2 to <12 Years) Who Are Virologically SuppressedNCT04012931 · 2019-07-18
COMPLETED
Effect on HIV Medications on EPC CellsNCT03782142 · 2018-11-01
COMPLETED
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive ImplantNCT03589040 · 2018-09-25
UNKNOWN
Darunavir and Rilpivirine Interactions With Levonorgestrel ImplantNCT03589027 · 2018-08-07
UNKNOWN
Efficacy of Rilpivirine-based Regimens as Switch Therapy From Nevirapine-based Regimens in HIV-infected PatientsNCT03664440 · 2016-12-01
COMPLETED
A Roll-over Study With Rilpivirine for Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Who Participated in Rilpivirine Pediatric StudiesNCT02494986 · 2015-07-06
ACTIVE_NOT_RECRUITING
Rilpivirine in Virologically Suppressed AdolescentsNCT03033368 · 2015-07-01
UNKNOWN
Cost-effectiveness of Different Antiretroviral Treatment in Patients HIV NaiveNCT02470650 · 2015-06-01
WITHDRAWN
Open Label, Pilot Study of Darunavir Boosted by Cobicistat in Combination With Rilpivirine to Treat HIV+ Naïve SubjectsNCT02404233 · 2015-03-01
UNKNOWN
Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure ProphylaxisNCT02165202 · 2014-10-01
COMPLETED
Safety, Tolerability, Drug Interactions, and Antiviral Activity of Rilpivirine in Antiretroviral-Naive HIV-Infected Children Less Than 12 Years of AgeNCT01975012 · 2014-09-01
WITHDRAWN
A Clinical Trial Comparing the Efficacy of Tenofovir Disoproxil Fumarate/Emtricitabine/Rilpivirine (TDF/FTC/RPV) Versus TDF/FTC/Efavirenz (TDF/FTC/EFV) in Patients With Undetectable Plasma HIV-1 RNA on Current First-line TreatmentNCT01709084 · 2013-10-02
COMPLETED
Efavirenz Versus Rilpivirine on Vascular Function, Inflammation, and Oxidative StressNCT01585038 · 2012-07-01
COMPLETED
The Rilpivirine Cerebrospinal-fluid (CSF) StudyNCT01562886 · 2012-03-01
COMPLETED
A Trial With TMC278-TIDP6-C222 for Continued TMC278 Access in Patients Infected With Human Immunodeficiency Virus-1NCT01266902 · 2011-02-01
COMPLETED
A Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Activity of Rilpivirine (TMC278) in Human Immunodeficiency Virus Infected Adolescents and Children Aged Greater Than or Equal to 6 YearsNCT00799864 · 2011-01-01
COMPLETED
A Single-arm, Open-label, Study to Assess the Pharmacokinetics of Darunavir and Ritonavir, Darunavir and Cobicistat, Etravirine, and Rilpivirine in HIV-1 Infected Pregnant WomenNCT00855335 · 2009-04-09
COMPLETED
Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After PregnancyNCT00042289 · 2003-06-09
COMPLETED

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.